The /Msopropylmalate dehydrogenase (/MPMDH) gene of Acetobacter aceti No. 1023, which complementedthe leuB mutation of Escherichia coli, was cloned and expressed in E. coli. Plasmids pCALl and pCAL4, carrying a 5.44 kilobase pairs (kb) 7/wdIII-fragment in the opposite orientation, conferred the same /MPMDH activity as that of the wild type strain of E. coli. Restriction mapping and deletion analysis indicated that the /MPMDH gene was located on a 1.65 kb Aatll-Hindlll fragment. Plasmids pMVLl and pMVL2, composing the cloned /MPMDH gene and plasmid pMV102, a plasmid indigenous to Acetobacter, were constructed as plasmid cloning vectors which allow selection of leu+ transformants in an A. aceti leu~host. The A. aceti leu~host was obtained through the insertional inactivation occurring as a result of homologous recombination between the chromosome of A. aceti and the cloned /MPMDH gene, which was disrupted by insertion of the kanamycin resistance gene from pACYC177into the BamHI site in the Aatll-Hindlll fragment. This system constitutes a relatively simple technique for gene disruption or replacement in Acetobacter that requires a single transformation.
Acetobacter aceti is a strictly aerobic, Gramnegative bacterium exhibiting potent ability to oxidine ethanol into acetic acid, which is used for the industrial production of vinegar. For elucidation of the genetic background of this industrially important organism and improvement of strains by means of recombinant DNA technology, the development of hostvector systems for cloning genes in A. aceti cells is required. Wehave already developed a genetic transformation system for A. aceti1 '2) and a related organism, Gluconobacter suboxydans.3) We have also constructed several chimeric plasmids composing the cryptic plasmids of these organisms40 and drug resistnace plasmids from Escherichia coli, which allowed expression of the E. coli drug resistance genes in A. acetiia '5) and pMV102,a cryptic plasmid of A. aceti subsp. xylinum NBI1002,4) were used for cloning and construction of newvectors.
Media and cultivation. YPGand minimal media for Acetobacter, and LB mediumfor E. coli were described previously.1]
Davis' minimal medium8) supplemented with 30^g/ml ampicillin (Ap), 20^g/ml threonine and 2 /xg/ml thiamine was used for selection of E. coli transformants. The cultivation conditions and the concentrations of streptomycin (25 /xg/ml for A. aceti), ampicillin (30 /ig/ml for E. coli and 50/zg/ml for A. aceti) and kanamycin (30^g/ml for E. coli and 80/ig/ml for A. aceti) were the same as reported previously .2) Transformation. E. coli C600 was transformed by the method of Norgard Discussion. The ligation mixture was introduced by transformation into E. coli C600, and then Apr and Kmr transformants were selected. The plasmids isolated from the transformants were analyzed by restriction mapping.
Determination ofp-IPMDH activity. Cells of E. coli and A. aceti, harvested by centrifugation, were washed with 10mMTris-HCl (pH 8.0) and then suspended in 10mM Tris-HCl (pH 8.0) containing 20% glycerol. The cells were disrupted with a French press. After centrifugation at 10,000 x g for 60min, the supernatant was used as the cellfree extract. /MPMDH activity in the cell-free extract was assayed by the method described by Kisumi et either pCALl or pCAL4 showed almost the sameactivity as that of the wild-type strain of E. coli K12, although high-copy number plasmid pBR322 was used as the cloning vector. Thus, the promoter signal of the Acetobacter /MPMDHgene may not be efficiently recognized by the E. coli transcriptional machinery.
Localization of the fi-IPMDH gene in pCALl
To determine the coding region for the /?-IPMDHgene in the cloned insert in pCALl, we constructed various plasmids carrying deleted inserts, using pCALl as the starting material, and examined their ability to complement the leuB mutation ofE. coli C600. The results are summarized in Fig. 2 DNA.This type of one-step gene disruption has been widely used in yeast.14)
To confirm the insertional inactivation, pCALBam9 carrying the Kmr gene derived from E. coli plasmid pACYC177in the BamHl site in the Aatll-Hindlll insert of pCALAal l was prepared in E. coli cells as described in Materials and Methods and as summarized in Fig. 3 1  2  0  1  2  0  1  2   pMVLl  100  72  76  100  100  100  100  100  100  pMVL2  100  87  77  100  100  100  100  100  100 a The percentage ofleu+ cells was calculated as the ratio of the cell counts on the minimalmediumsupplemented with 20jug/ml of proline and 25^g/ml streptomycin to the cell counts on YPGmedium containing 25 jug/ml streptomycin.
b Number of successive cultivations (30°C, 24hr) in YPGmedium.
a selective marker. Plasmid pCALl was ligated to a cryptic Acetobacter plasmid, pMV102, for introduction of the replication origin for Acetobacter, and recombinant plasmids pMVLl and pMVL2 were constructed (Fig. 4) (Table IV) . The Kmr phenotype conferred by the integrated gene in the chromosomewas also retained stably. These plasmids, pMVLl and pMVL2, are the first vectors which have a genetic marker derived from Acetobacter, and are shuttle vectors for E. coli and A. aceti with double selection markers.
